We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical ...

NIH’s plan to cut what it pays universities and other entities for indirect costs associated with scientific research would create “extremely challenging” short- and long-term impacts, according to a ...

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at ...

Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...